Douglas Gregory is Executive Director, European Union Policy and Government Affairs at Amgen. He is responsible for coordinating and advancing Amgen interests to the EU Institutions and to the Organisation for Economic Cooperation and Development (OECD). Amgen participates in industry associations and other platforms such as the European Federation of Pharmaceutical Industries and Association (EFPIA), EuropaBio, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the American Chamber of Commerce to the EU and Business at OECD (BIAC). Mr. Gregory chairs the EFPIA Working Group on Healthcare Systems and is an active contributor to the OECD’s work on health policy.
With 30 years of experience in public policy advocacy, Mr. Gregory builds relationships with key stakeholders based on relevance, thought leadership, integrity and trust. He has provided expert testimony to the European Parliament, The World Trade Organisation (WTO), The Organisation for Economic Cooperation and Development (OECD) and the United Nations Commission for Trade and Development (UNCTAD).
Amgen is inscribed in the Joint Transparency Register of the European Parliament and the European Commission. Mr. Gregory is accredited to the European Parliament.